Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto, K., . . . Oya, M. (2019). Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer. Cancer Sci.
Citação norma ChicagoOgihara, Koichiro, et al. "Sulfasalazine Could Modulate the CD44v9‐xCT System and Enhance Cisplatin‐induced Cytotoxic Effects in Metastatic Bladder Cancer." Cancer Sci 2019.
MLA citiranjeOgihara, Koichiro, et al. "Sulfasalazine Could Modulate the CD44v9‐xCT System and Enhance Cisplatin‐induced Cytotoxic Effects in Metastatic Bladder Cancer." Cancer Sci 2019.
Opozorilo: Ti citati niso vedno 100% točni.